Shree Ganesh Bio-Tech (India) Ltd

NSE: SHREEGANES · BSE: 539470 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹0.47
Market cap: ₹18.74 Cr
Revenue (annual): ₹4.97 Cr
Net profit (annual): ₹0.38 Cr
P/E (TTM): -48.5×Sector 50.4×
Promoter holding: 0.00%+0.00% QoQ
FII holding: 1.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements

3 Sep 2026 11:57 IST BSE

Annual Report

Shree Ganesh Bio-Tech (India) Annual Report

Shree Ganesh Bio-Tech (India) Limited has released its Annual Report for the financial year 2025-26. The 16th Annual General Meeting is scheduled for September 28, 2026.

Read the filing ↗

3 Sep 2026 11:26 IST BSE

Annual General Meeting

Shree Ganesh Bio-Tech (India) Annual General Meeting

Shree Ganesh Bio-Tech (India) Limited has issued a notice for its 16th Annual General Meeting. The meeting is scheduled for September 28, 2026, at the registered office.

Read the filing ↗

4 Aug 2026 16:16 IST BSE

Financial Results

Shree Ganesh Bio-Tech (India) Q1 FY27 Results: Net Loss of ₹0.6 Cr

Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹1.4 Cr (+0.0% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.

Key figure: Net loss ₹0.6 Cr

Open full results → Read the filing ↗

14 May 2026 17:38 IST BSE

Financial Results

Shree Ganesh Bio-Tech (India) Q4 FY26 Results: Net Loss of ₹0.1 Cr, Loss Narrows

Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹2.1 Cr (-30.0% YoY) and a net loss of ₹0.1 Cr for Q4 FY26.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗